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ABSTRACT
Daily administration of estrogen to immature female chicks results in marked oviduct
growth and appearance of characteristic tubular gland cells which contain lysozyme. Al-
though a rapid increase in total DNA and RNA content begins within 24 hr, cell specific
protein, lysozyme, is first detectable after 3 days of estrogen . Progesterone administered
concomitantly with estrogen antagonizes the estrogen-induced tissue growth as well as
appearance of tubular gland cells and their specific products, lysozyme and ovalbumin.
When the initiation of progesterone administration is delayed for progressively longer
periods (days) during estrogen treatment, proportionally greater growth occurs with more
lysozyme and tubular gland cells after 5 days of total treatment. Progesterone does not
inhibit the estrogen-stimulated increase in uptake of a-aminoisobutyric acid and water by
oviduct occurring within 24 hr or the estrogen-induced increase in total lipid, phospholipid,
and phosphoprotein content of serum . The above results of progesterone antagonism can
best be explained by the hypothesis that progesterone inhibits the initial proliferation of
cells which become tubular gland cells but does not antagonize the subsequent cytodiffer-
entiation leading to the synthesis of lysozyme and ovalbumin once such cell proliferation
has occurred.
INTRODUCTION
The chick oviduct provides an excellent system
for the study of hormonal regulation of growth,
cytodifferentiation, and function of specific cell
types. The growth of the oviduct is markedly
stimulated by estrogen (1-3) . In addition, the
synthesis of specific cell products such as lysozyme
816
and ovalbumin is induced by estrogen in the
magnum portion of oviduct (4-8). Various effects
of progesterone on the responses of the oviduct to
estrogen have been described . Thus, Hertz et al.
first reported that avidin synthesis is induced by
progesterone in an estrogen-primed oviduct (9).More recently O'Malley and his collaborators
have shown that the above effect of progesterone
can be demonstrated in an estrogen-stimulated
minced oviduct and oviduct epithelial cells in
culture (10-12). In contrast, several workers have
reported that progesterone administered con-
comitantly with estrogen inhibits estrogen-induced
growth (13-16), while a synergistic effect of pro-
gesterone has also been described (16-18) .
In a recent communication (19) we described
some aspects of an antagonistic effect of con-
comitant progesterone administration on the
estrogen-induced cytodifferentiation of tubular
gland cells, cells which are involved in synthesis of
the egg white proteins, ovalbumin, and lysozyme .
We proposed that progesterone antagonizes the
proliferation of those cells destined to become tubu-
lar gland cells, cells that comprise a major portion
of the estrogen-stimulated oviduct. Our results
also suggested that once such proliferation takes
place, the subsequent processes of cytodifferentia-
tion are not inhibited by progesterone .
In the present paper, we report in more detail
on the progesterone antagonism of estrogen-in-
duced oviduct development . In addition, we show
here that the antagonism produced by progesterone
is tissue specific and noncompetitive with estrogen .
In addition, progesterone does not inhibit the
early (4-12 hr) effects of estrogen to increase the
amino acid and water uptake into the oviduct .
MATERIALS AND METHODS
Hormones and Chemicals
17/3-estradiol benzoate, progesterone, testosterone
propionate, and hydrocortisone 21-phosphate were
obtained from Nutritional Biochemicals Corporation,
Cleveland, Ohio. Calf thymus DNA and yeast RNA
were obtained from Worthington Biochemical Corp .,
Freehold, N.J. The strain of Micrococcus lysodeikticus
was kindly provided by Dr. C. E. Nardini, Depart-
ment of Medical Microbiology, Stanford Medical
School.
Treatment of Animals
Newborn white leghorn female chicks obtained
from Kimber Farms, Fremont, Calif., were main-
tained in electrically heated brooders and fed a
Purina Laboratory Chow (micro-mixed) diet (Ral-
ston Purina Co., St. Louis, Mo.) . At the age of 4
days, the chicks, weighing about 50 g each, were
given the hormone(s) dissolved in sesame oil or 0.15
M saline (in the case of hydrocortisone) . The volume
of injection was 0.1 ml per chick for each hormone;
injections were given into the separate muscle mass
of opposite limbs just below the knee when two hor-
mones were administered.
Assays
At indicated times after hormone administration,
chicks were sacrificed by decapitation, and oviducts
were promptly dissected. The magnum part of the
oviduct was removed, weighed and homogenized
in a motor-driven glass homogenizer with 9 volumes
(w/v) of ice-cold distilled water. DNA and RNA
were extracted from the homogenate by the method
of Schneider (20). DNA was assayed by the diphenyl-
amine reaction with calf thymus DNA as standard
(21), and RNA was assayed by the orcinol method
with yeast RNA as standard (22) . Protein was esti-
mated by the method of Lowry et al. (23) with crystal-
line bovine serum albumin as standard . Lysozyme
was assayed by a modification of the method of Lit-
wack (24) . The activity was measured by following
the decrease in absorbancy at 645 my at 25' C with
Gilford Multiple Sample Absorbance Recorder
Model 2000 (Gilford Instrument Company, Oberlin,
Ohio) attached to a Beckman DU monochromator
(Beckman Instruments Inc., Fullerton, Calif.). The
reaction mixture consisted of 2.5 ml of 0.066 M po-
tassium phosphate buffer, pH 6 .2, containing 0.1%
NaCl and Micrococcus lysodeikticus 75 mg dry weight/
100 ml and enzyme solution. Activity is expressed as
,ug of lysozyme present and is based on the activity of
purified egg white lysozyme (Calbiochem, Los
Angeles, Calif.) as standard. Addition of oviduct
extract to the purified lysozyme resulted in additive
enzyme activity in all cases. Hence no activator or
inhibitor of lysozyme could be demonstrated in
oviduct extract.
Serum was collected from the jugular vein for the
determination of total lipid, phospholipid, and phos-
phoprotein in serum. Total lipid and phospholipid
were extracted from serum with a chloroform-metha-
nol mixture (2 : 1, v :v), and the extract was washed
with 0.05% sulfuric acid to remove nonlipid sub-
stances (25) . Total lipid content in serum was esti-
mated with palnutic acid as standard by measuring
the amount of chromium potassium sulfate produced
from potassium dichromate spectrophotometrically
at 580 mµ in a Zeiss spectrophotometer, Model PMQ
II (26) . Phospholipid was estimated by measuring
the phosphorus content in the chloroform-methanol
extracts according to Fiske and SubbaRow (27) .
Phosphoprotein in serum was extracted and measured
as described by Greengard et al. (28) .
Counting Procedures
"C-a-aminoisobutyric acid (SA, 5 .1 me/mmole)
was obtained from New England Nuclear Corp .,
Boston, Mass. It was dissolved in 0.15 M NaCl, and 1
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817µc per chick was injected intramuscularly (breast
muscle) in a volume of 0.1 ml 4 hr before hormone
administration . At indicated times after hormone
administration, oviduct and other tissues were dis-
sected, placed in scintillation vials, and dried for 24
hr at 84° C in the oven. Dried tissues were weighed,
soaked in 0.1 ml of distilled water, and then solubi-
lizcd in I nil of NCS (Nuclear-Chicago Corporation,
Des Plaines, Ill .) at 45° C for 4 hr. 10 ml of toluene
scintillator containing 0 .4 0 /, 2,5-diphenyloxazole
and 0.01% 1,4-bis[2-(5-phenyloxazolyl)]-benzene
(Packard Instrument Co ., Inc., Downers Grove, Ill.)
was added and radioactivity was measured in a Pack-
ard liquid scintillation spectrometer model No. 3310
with counting efficiency of 53c% c. The background
was 29 cpm.
Immunologic Procedures
Antibodies against lysozyme and ovalbumin were
prepared in adult male albino rabbits as described
by Leskowitz and Waksman (29). An 0.15 M NaCl
solution (0.5 ml) containing 2 .5 mg of purified lyso-
zyme (Calbiochem, Los Angeles, Calif.) or ovalbumin
(General Biochemicals, Div ., Chagrin Falls, Ohio)
was emulsified with complete Freund's adjuvant
(Difco Laboratories, Detroit, Mich.) and injected
into toe pads of rabbits . Acrylamide gel electrophore-
sis (30) of 20 µg of either purified lysozyme or purified
ovalbumin preparation showed one major band for
each protein. 2 weeks after immunization, sera were
collected and were subjected to partial purification
by ammonium sulfate fractionation. The globulin
fraction precipitating between 30 and 33% ammo-
nium sulfate saturation was dissolved in 0.01 M po-
tassium phosphate buffer and 0.15 M NaCl mixture,
pH 7.2, and was dialyzed against this solution for 36
hr (31) . Control antiserum prepared from rabbits
receiving injections of Freund's adjuvant-0. 15 M
NaC1 mixture was treated in a similar fashion . Re-
activity of antibody against lysozyme was assessed
by the following experiment : Increasing amounts of
anti-lysozyme serum were added to a constant amount
of either purified lysozyme or lysozyme present in
oviduct extracts. After incubation at 37° C for 30
min and then at 4° C for 24 hr, the resultant antibody-
antigen complex was removed by centrifugation
and the supernatant was assayed for enzyme activity.
It was found that the loss in lysozyme activity was
proportionately related to the amount of antibody
added until the complete loss in enzyme activity was
reached. Control antiserum failed to cause such a loss
in lysozyme enzyme activity by the above assessment.
Ouchterlony agar diffusion tests were performed
as outlined by Kabat and Mayer (32) with 1 %
agar (Noble Agar, Difco Laboratories, Detroit, I The authors are grateful to Dr. A. H. Saunders,
Mich.) in 0.15 M NaCl adjusted to pH 8 .0 with I M Department of Pathology, Stanford Medical School
NaOH. Immunoelectrophoresis was performed for assistance with the immunofluorescent studies.
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according to the manual obtained from Buehler
Instruments Inc., N. J. (33). The electrophoresis was
performed in 0 .01 M veronal buffer pH 8.7, ionic
strength 0 .075, for 2.5 hr with 2.5 mamp per slide
with a total voltage of 70-90 volts . Oviduct extracts
for immunologic analyses were made as follows :
Oviducts were homogenized in 9 volumes (w/v)
of 0.001 M MgCl7, 0.001 M potassium phosphate
buffer, pH 6.8, and were centrifuged for 10 min at
10,000 g in Servall RC2-B at 4° C and then for 60
ruin at 105,000 g in Spinco Model L ultracentrifuge
at 4 ° C. The resulting supernatant was used for all
studies.
For fluorescent antibody staining, the indirect
method was used (34) . 5-µ thick sections of the mag-
nam were prepared as described below in the his-
tological procedures. After successive treatment in
toluene, the graded alcohols, and water, the sections
were treated with the rabbit antiserum to lysozyme
for 15 min at 25 ° C and then incubated for 30 min
at 25° C with a fluorescein conjugate of a goat anti-
rabbit globulin antiserum (Microbiological Asso-
ciates Inc ., Bethesda, Md.). The specificity of the
staining was controlled by (1) adding anti-rabbit
antibody conjugate to the sections without pretreat-
ment with rabbit anti-lysozyme serum, (2) adding
control rabbit serum instead of anti-lysozyme anti-
serum to the sections before incubation with the
conjugate, and (3) adding a conjugate of normal
goat globulin instead of goat anti-rabbit globulin .
For microscopy, a Zeiss GFL research microscope,
equipped with a basic camera body V, was used . The
light source was a PEK short-arc mercury lamp which
was operated by a PEK model 401 DC power supply
(PEK Labs, Inc., Sunnyvale, Calif.) . Photomicro-
graphs were taken on Kodak Tri-X Pan film' (35).
Histological Procedures
For histological examination, portions of the
magnum were fixed in 0.01 M sodium phosphate
buffer, pH 7.2, containing 4% glutaraldehyde (36).
Following dehydration in the graded alcohols and
clearing in toluene, the tissues were embedded in
paraffin. 5-A thick sections were stained with Mayer's
hematoxylin and eosin.
RESULTS
Effect of Estrogen and its Combination with
Other Steroid Hormones on Oviduct
Wet Weight
As shown in Fig . 1, daily administration of
estrogen results in a marked increase in wet weight.Following an initial lag of 3 days, the increase is
rapid, amounting to 500-fold in 10 days . Con-
comitant administration of progesterone with
estrogen markedly inhibits the estrogen-stimulated
increase in wet weight, although this treatment still
increases the wet weight considerably . In accord-
ance with the previous work of Breneman (18),
and Zarrow et al. (37), testosterone is synergistic
and hydrocortisone is somewhat antagonistic to
estrogen in increasing the wet weight when ad-
ministered with estrogen. Thus 10 days of daily
administration of estrogen with testosterone or
with hydrocortisone results in more than 700-fold
and about 400-fold increases, respectively . Ad-
ministration of testosterone or progesterone alone
for 10 days results in 10- and 20-fold increases,
respectively, whereas only a 2-fold increase occurs
in oviducts of chicks receiving hydrocortisone or
no hormone treatment.
Effect of Estrogen and its Combination with
Other Steroid Hormones on Lysozyme
Content in Oviduct
As shown in Fig. 2, no lysozyme is detectable
during the first 2 days of estrogen treatment . A
barely measurable activity appears by the 3rd day.
Thereafter the content of lysozyme increases
rapidly such that the rate of its accumulation
exceeds that of the increase in total wet weight
between the 6th and 8th day of estrogen adminis-
tration. Concomitant administration of proges-
terone with estrogen prevents the appearance of
lysozyme throughout the 10-day treatment period .
In an occasional experiment a very small amount
of lysozyme activity is detected after 5 and 10
days of combined estrogen-progesterone treat-
ment. Hydrocortisone administered with estrogen
reduces slightly the estrogen-induced increase in
lysozyme content, whereas the combined treat-
ment of estrogen and testosterone results in greater
increase in lysozyme content than estrogen treat-
ment alone. There is no measurable lysozyme in
the oviducts from untreated, progesterone-, hydro-
cortisone-, and testosterone-treated chicks.
Effect of Estrogen and its Combination with
Progesterone on DNA, HNA and Total
Protein Content in Oviduct
As shown in Table I, within 3 days of estrogen
treatment, total DNA content increases markedly,
indicating that extensive cell proliferation has
5
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FIGURE 1 Changes in wet weight of the oviduct
during daily treatment with various hormones. Chicks
were treated with 177-estradiol benzoate (E) alone
or its combination with testosterone propionate (ET),
progesterone (EP), and hydrocortisone 21-phosphate
(EH) for 10 days. The insert shows the changes in wet
weight of the oviduct from chicks treated with testos-
terone propionate (T), progesterone (P), hydrocorti-
sone 21-phosphate (H) and control sesame oil (C)
for 10 days, respectively . The dose of each hormone is
1 ing day per chick. Each point represents the means ±
SEM of four chicks.
occurred during the initial lag period in wet
weight increase and before lysozyme appearance .
The DNA concentration (milligrams/gram tissue)
decreases during this period, due largely to the
imbibition of water into the tissue provoked by
estrogen (see following paragraph) . With con-
tinued estrogen treatment, the concentration of
DNA declines further although the total DNA
continues to increase . The RNA concentration
as well as total content, and the RNA/DNA ratio
increase during the lag period. In contrast, the
protein concentration does not increase markedly
until 3 days after the estrogen treatment, at which
time lysozyme begins to appear (Fig. 2) . There-
after the protein concentration increases more
than threefold with a marked increase in total
content by 10 days. Combined treatment with
estrogen and progesterone results in a significant
decrease in the estrogen-stimulated increase in
total DNA, RNA, and protein content (P = 0.01) .
Likewise, the concentrations of DNA, RNA, and
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FIGURE 2 Changes in lysozyme activity in the mag-
num portion of the oviduct during daily treatment of
various hormones. Chicks were treated with 17/3-
estradiol benzoate (E) alone or its combination with
testosterone propionate (ET), progesterone (EP),
and hydrocortisone 21-phosphate (EH) for 10 days.
The dose of each hormone is I mg/day per chick .
Enzyme activity is expressed as milligrams/gram wet
weight magnum. Each point represents the means f
sEM of four chicks.
protein are lower during the 10-day period
(E vs. EP).
E ffect of Estrogen and its Combination with
Progesterone on the Histology of the
Magnum Portion of Oviduct
LOW MAGNIFICATION : The appearance of
the magnum from chicks treated with estrogen
for 5 days is presented in Fig. 3 b. In contrast to
the untreated control (Fig. 3 a), the size of the
magnum is markedly increased with an increase
in inner epithelial layer and outer muscle layer
(note the difference in magnification of the two
photomicrographs). The most prominent dif-
ference, however, is found in the glandular por-
tion of the magnum, that area between epithelial
and serosal surfaces, which comprises the bulk of
the entire magnum. This area is occupied almost
entirely by numerous nests of cells containing
eosinophilic granules. As shown in Fig. 3 c, con-
comitant administration of progesterone with
estrogen for 5 days results in a markedly altered
appearance. Thus, the expansion of the glandular
portion is essentially absent and the characteristic
nests of cells containing an eosinophilic substance
are not present. There is, however, a considerable
increase in size of the magnum compared to the
TABLE I
Changes in DNA, RNA, Protein and Lysoyyme in the Magnum Portion of Oviduct
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RNA
	
Protein
C5 and CIO	5 and 10 days of control sesame oil administration, respectively .
E3, E5, E7, ElO - - --	3, 5, 7, and 10 days after daily administration of 17/3-estradiol benzoate (1 mg/
day per chick), respectively.
EP3, EP5, EP7, EP1O . . . .3, 5, 7, and 10 days after daily administration of 17$-estradiol benzoate (1 mg/
day per chick) and progesterone (1 mg/day per chick), respectively .
Each value represents the mean t sEM of 4 chicks.
Treat-
ment µg/magnum
mg/g magnum
wet weight µg/magnum
mg/g magnum
wet weight
RNA/
DNA mg/magnum
mg/g magnum
wet weight
C5 33 t 2 6 .5 f 0.1 35 f 4 7 .0 f 0 .1 1 .1 0 .4 f 0.1 75 f 1
CIO 49 t 3 6 .4 f 0.1 50 f 2 7.1 ± 0 .2 1 .1 0.6 f 0.1 70 t 5
E3 171 f 5 3 .0 f 0 .2 518 f 19 9.2 f 0 .1 3 .1 5.7 f 0.4 86 f 4
E5 485 t 7 2 .6 f 0 .2 1695 t 23 9.4 f 0 .2 3 .6 19.8 f 1 .2 128 f 5
E7 730 t 10 2 .4 f 0 .2 2390 f 21 8.4 ± 0.1 3 .5 42 .3 f 1 .1 139 t 7
ElO 1010 t 22 2 .3 f 0 .2 3850 f 20 8.0 f 0.1 3 .5 112 .2 f 1 .8 195 t 10
EP3 70 t 2 2 .1 t 0.1 140 f 7 4 .2 ± 0 .1 2 .0 3 .1 t 0 .2 80 f 2
EP5 110 zb 6 2 .0 f 0 .2 267 f 4 4.8 f 0.1 2 .4 5 .2 t 0 .2 99 t 5
EP7 210 ± 8 1 .9 f 0.1 380 t 15 4 .0 f 0 .2 2 .1 8 .1 f 0 .1 90 ± 7
EPIO 300 t 8 1 .8 f 0.2 440 zL 20 3 .9 f 0 .2 2 .2 12 .0 f 0 .2 102 f 3FIGURE 3 a-d Effect of estrogen and its combination with progesterone in the histology of the magnum
portion of the oviduct : low magnification. 3 a. no hormone treatment. X 130. 3 b. 5 days of daily estrogen
treatment. X 28. 3 c. 5 days of daily combined treatment with both estrogen and progesterone. X 41.
3 d. 2 days of daily estrogen treatment and 3 days of daily combined treatment with both estrogen and
progesterone. X 31. 17/3-estradiol benzoate and progesterone were administered at a dose of 1 mg/day
per chick.
untreated control, although the increase is not so
marked as that in the estrogen-stimulated magnum.
In Fig. 4, indicated regions of the sections in
Fig. 3 have been magnified further, to show more
detailed characteristics of the cell types. As shown
in Fig. 4 b, tubular gland cells occupy essentially
the entire section of the magnum of chicks treated
with estrogen for 5 days, whereas only stromal
cells are present in this region of the untreated
gland (Fig. 4 a) . Characteristic of tubular gland
cells is a distinct, basal nucleus and deeply stain-
ing small granules in the apical region . The gland
lumina are formed by the assembly of such tubular
gland cells and are often filled with small granules.
Unlike the estrogen-treated magnum, tubular
gland cells are absent when chicks are treated
with both estrogen and progesterone for 5 days
(Fig. 4 c). In addition, no densely eosin-staining
granules are found in any portion of the magnum .
Instead, stromal cells are abundant in this region
as in the untreated gland (Fig. 4 a). Another notice-
able feature of progesterone treatment is its effect
on the variety and structure of cells in the lining
epithelium of the magnum (Fig . 4 c) . Thus, the
epithelial cells are distinctly more columnar than
those in the epithelium from chicks that have
received estrogen alone (Fig. 4 b) . In addition,
various types of cells are evident, some with cilia,
TAKAMI OKA AND ROBERT T. SCIIIMKE Hormone Interaction in Oviduct Development 821FIGURE 4 a-d Effect of estrogen and its combination with progesterone on histology of the magnum
portion of the oviduct: high magnification. The indicated sections of the magnum presented in Fig . 3.
4 a. no hormone treatment. X 660. 4 b. 5 days of daily estrogen treatment . X 340. 4 c. 5 days of daily
combined treatment with both estrogen and progesterone . X 420. 4 d. 2 days of daily estrogen treatment
and 3 days of daily combined treatment with both estrogen and progesterone . X 340.
some with nuclei that are placed centrally, and
others with basally placed nuclei . Thus, whereas
progesterone essentially abolishes formation of
one cell type, i.e. tubular gland cells, it enhances
differentiation of other cell types, i.e. epithelial
cells.
IMMUNO FLUORESCENT STAINING : Sections
of the magnum from the chicks treated with
estrogen for 5 days were subjected to fluorescent
antibody staining to localize lysozyme . As shown
in Fig. 5 a, lysozyme is localized specifically in
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tubular gland cells. No lysozyme is localized in the
cells of the lining epithelium or of the serosal sur-
face. In the magnum from untreated chicks or
from chicks treated for 5 days with both estrogen
and progesterone where no tubular gland cells are
found histologically (Fig. 4 c), there is also no
evidence of lysozyme by this technique. Kohler
et al. also localized ovalbumin in the tubular
gland cells of the estrogen-stimulated magnum
by a similar technique (6) .FIGURE 5 a-b Localization of lysozyme by inununofluorescent staining . Cross sections of the magnum
of chicks treated with : 5 a. estrogen for 5 days. X 140. 5 b. estrogen for 2 days, and estrogen plus proges-
terone for 3 days. X 210. 17/3-estradiol benzoate and progesterone were administered at a dose of I mg/
day per chick.
Immunologic Analysis of Lysozyme and
Ovalbumin in the Nontreated,
Estrogen-Treated and
Estrogen-Progesterone-Treated Oviduct
As shown in Figs. 6 and 7, immunologic analyses
by both Ouchterlony double diffusion and im-
munoelectrophoresis techniques reveal that oviduct
extracts prepared from chicks treated with estrogen
for 5 days contain both ovalbumin and lysozyme .
The immunoelectrophoresis pattern for ovalbumin
shows two major bands, one which coincides with
purified egg white ovalbumin in electrophoretic
mobility and the other which does not migrate
under the experimental conditions . Whether these
two bands represent different yet immunologically
reactive ovalbumins is unknown. In this connec-
tion, it is interesting to note that at least two re-
ports (38, 39) show that three different ovalbumins
have been isolated from hen oviduct, each having
a different electrophoretic mobility due to the
differences in degree of phosphorylation . The
oviduct extracts prepared from the untreated
chick or from the oviducts of chicks treated with
estrogen plus progesterone for 5 days do not con-
tain ovalbumin and lysozyme as detected by
these methods (Fig. 6, 7) .
Effect of Progesterone Administered at Various
Times After the Onset of
Estrogen Administration
From the difference in time of the onset of the
estrogen-induced cell proliferation and of the
onset of the appearance of lysozyme (Fig . 2 and
Table I), it would appear that estrogen first
stimulates the proliferation of those cells, which,
within 2-3 days, become tubular gland cells and
synthesize lysozyme and ovalbumin . To deter-
mine the point in time when progesterone antago-
nizes the effects of estrogen on this process, pro-
gesterone administrations were initiated from 0
to 5 days after the onset of estrogen administrations .
5 and 10 days after the initial estrogen administra-
tion changes in wet weight, total content, and con-
centration of DNA, RNA, protein and lysozyme
in the magnum were examined for the effect of
the delay in the onset of progesterone administra-
tion. As shown in Table II, even a I day delay in
the onset of progesterone administration allows
for estrogen to induce a detectable amount of
lysozyme as well as a significant increase in the
total content of DNA by the 5th and 10th day
(El EP4 vs. EP5, El EP9 vs. EP10). As the onset
of progesterone administration is delayed longer,
the increase in total DNA, RNA, and protein
content becomes proportionately greater . Further-
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823FIGURE 6 a-b Iinmunologic analysis of lysozyme and
ovalburnin. Ouchterlony double diffusion. The center
wells of Fig. 6 a and b contained 0.2 nil of lysozyme
antibody (LA) and ovalburnin antibody (OVA),
respectively. Side wells of each plate contained 0 .2
nil of oviduct extracts (0 .4 mg protein/ml) prepared
from the chicks treated with 17,3-estradiol benzoate
(1 mg/day per chick) for 5 days (E), its combination
with progesterone (1 mg/day per chick) for 5 days
(EP), and sesame oil control (C) as desciibed under
Materials and Methods. Side wells of each plate also
contained purified lysozyme (L) and ovalburnin (0V)
as standard. The patterns were allowed to develop for
14 days at 25° C before photography.
more, the amount of lysozyme also increases pro-
gressively with the length of delay in the onset of
progesterone administration, as depicted graph-
ically in Fig. 8. The increase in total DNA, RNA,
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protein, and lysozyme contents correlates well
with the increase in the delay in onset of proges-
terone administration during 5 days of estrogen
treatment. This correlation also can be seen from
a histological examination of the magnum from
chicks treated for 2 days with estrogen followed
by 3 days of combined estrogen and progesterone
treatment (E2 EP3). As seen in Fig. 3 d, the
magnum from E2-EP3-treated chicks shows a
picture somewhat like the one of the magnum
from E5-treated chicks. Thus, there is an increase
in size of the magnum and an enlargement of the
glandular portion, both of which, however, are
less extensive than they are in the E5-treated
magnum. The scattered nests of cells containing
an eosinophilic substance are more closely asso-
ciated with the epithelial layer, and the lumina
formed by such cells are not completely filled with
an eosinophilic substance as is the case in the E5-
treated magnum. In addition, as shown in Fig .
4 d, such cells are not so columnar as those tubular
gland cells in the E5-treated magnum (Fig . 4 b) .
Such tubular gland cells contain lysozyme as
shown by immunofluorescent staining (Fig . 5 b) .
The central region of the tissue is, however,
occupied by stromal cells, which appear similar
to those present in the EP5 treated magnum
(Fig. 4 c) . Thus, the magnum from E2-EP3-
treated chicks exhibits certain characteristics of
both the E5- and the EP5-treated magnum . Such
histological findings are consistent with the bio-
chemical data presented above, indicating that
during the period before the initiation of proges-
terone treatment estrogen stimulates the prolifera-
tion of cells which subsequently become tubular
gland cells and synthesize lysozyme . Concomitant
administration of progesterone prevents this pro-
liferation. However, once such proliferation has
occurred, the cytodifferentiation and lysozyme
appearance are not prevented by progesterone
administration.
Some Characteristics of Progesterone
Antagonism to Estrogen
In order to examine whether the antagonistic
effect of progesterone is competitive or noncom-
petitive, the effect of increasing dosages of estrogen
on the magnum wet weight increase was studied
under variable doses of progesterone. Results
presented in Fig. 9 show that the inhibitory effect of
progesterone is noncompetitive, since at least a
four-fold increase in the dosage of estrogen is in-FiGUmE 7 a-d Immunologic analysis of lysozyme and ovalbumin-immunoelectrophoresis. Center
trough of Fig. 7 a-d contained 0.025 ml of lysozyme antibody and ovalbumin antibody, respectively.
Aliquots of oviduct extracts prepared from the chicks treated with 17/3-estradiol benzoate (1 mg/day per
chick) for 5 days (E), its combination with progesterone (1 mg/day per chick) for 5 days (EP), and
sesame oil control (C) were added to the side wells as indicated . Purified lysozyme (L) and ovalbumin
(OV) were also added to the side well as standard. The patterns were allowed to develop for 24 hrs at
25° C, leached out, and stained with Ponceau S before photography .
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Weffective in reversing the inhibitory effect of
progesterone on the estrogen-stimulated increase
in wet weight. It can also be seen that the degree
of progesterone inhibition of the estrogen effect is
approximately proportional to the dose of pro-
gesterone administered. With a maximum dose
of progesterone (I mg/day per chick), the in-
crease in wet weight is essentially the same re-
gardless of the dosage of estrogen administered
ranging from 0.25 to 4 mg/day per chick .
100
F -
Z
w 60
0
w
a
20
0
o WET WEIGHT
•
	
DNA
∎ RNA
•
	
PROTEIN
•
	
LYSOZYME
FIGURE 8 Effect of the delay in the onset of proges-
terone administration on estrogen-stimulated increase
in total DNA, RNA, protein, and lysozyine of chick
oviduct. Increases are described as percent of values
obtained after 5 days of estrogen treatment . Details
are given in Table II.
IJEM
4-
4
- .25.5 1
	
- .25 .5 1
-1
T
4-
0
E m g .1 .1 .1 .1 .25.2525.25
Pmg - .25 .5 1
Estrogen treatment of the chick induces a
marked lipemia and the appearance of a specific
phosphoprotein in serum (40) . As shown in Table
III, specific phosphoprotein content as well as
total lipid and phospholipid content in serum is
increased markedly by estrogen administration .
Concomitant administration of progesterone with
estrogen does not inhibit this effect of estrogen .
These findings confirm the report of Hertz et al .
(13) and indicate that progesterone antagonism
is rather specific for the oviduct .
In rat and rabbit uteri, one of the early changes
induced by estrogen is the increased uptake of
amino acids (41-43) and water (44). It might be
possible that progesterone exerts its inhibitory
effect by blocking one of these early changes
caused by estrogen . The effect of estrogen and its
combination with progesterone on the uptake of a
nonmetabolizable amino acid, a-aminoisobutyric
acid, was studied to test this possibility. As shown
in Fig. 10, increased uptake of a-aminoisobutyric
acid is noted as early as 2 hr and reaches the
maximum around 12 hr after estrogen adminis-
tration. This effect is sustained for over 24 hr .
Progesterone, by itself, increases the uptake of
a-aminoisobutyric acid to a lesser extent than
estrogen. The combination of progesterone with
estrogen results in the same degree of increase as
found after estrogen administration . This effect
of estrogen is relatively specific for oviduct since
the kinetics of a-aminoisobutyric acid uptake in
+4 4-
1-
.5 .5 .5 .5
	
1 1 1 1
	
2 2 2 2
	
4
- .25.5 1
	
- .25.5 1
	
- .25.5 1
	
- .25.5
4 4 4
1
FIGURE 9 Effect of increasing dosage of estrogen (E) on the magnum wet weight under variable doses of
progesterone (P). Chicks were treated with hormone(s) in the combination of doses indicated, daily for 5
days. Each column represents the means t sEM of four chicks.
TAKAMI OKA AND ROBERT T. SCHIMKE Hormone Interaction in Oviduct Development 827TABLE III
Effect of Progesterone on the Estrogen-Induced
Increase in Total Lipid, Phospholipid and Phos-
phoprotein
* Chicks were treated with 170-estradiol benzoate
(1 mg/day per chick), progesterone (1 mg/day
per chick) and their combination for 5 days .
Control chicks were given sesame oil for 5 days .
Each value represents the mean of 2 determina-
tions .
liver and plasma are not affected by either
estrogen or progesterone over the 24-hr period.
There is, however, a transient increase in a-amino-
isobutyric acid uptake into the skeletal muscle
during the first 4 hr of either estrogen or combined
estrogen-progesterone treatment.
Fig. 11 shows the pattern of increase in wet
weight and dry weight of the oviduct occurring
within 24 hr following the administration of
estrogen, progesterone, and their combination .
The initial rise in wet weight is already notable at
4 hr and reaches its first peak at about 8 hr after
estrogen administration. During this initial in-
crease in wet weight, dry weight remains rather
constant as shown in the insert in Fig. 11, in-
dicating that there is an increase in the uptake of
water by the oviduct. Following the slight decline
in wet weight, there is a second, continuous rise
in wet weight which is accompanied by an in-
crease in dry weight after 16 hr of estrogen treat-
ment. Concomitant administration of progesterone
with estrogen does not affect either the estrogen-
induced uptake of water or the increase in wet
weight to any great extent. Progesterone adminis-
tration alone induces similar changes but to a
lesser degree than estrogen.
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FIGURE 10 Effect of estrogen, progesterone, and
their combination on uptake of a-aminoisobutyric
acid by chick tissues. Chicks were given a single in-
jection of either 17/3-estradiol benzoate (E) 1 mg per
chick, or progesterone (P) I mg per chick, or their
combination (EP) 1 mg each per chick, or control
sesame oil (C). At the indicated times after the hor-
mone treatment, the level of a aminoisobutyric acid
was determined for oviduct, liver, nmscle, and serum .
Radioactivity is expressed as counts per minute/milli-
gram dry weight or counts per minute/microliter
serum. Each point represents the mean of three values.
E oviduct, (0--*) EP oviduct,
(~	~) P oviduct, (A	A,) C oviduct;
(El	El) E skeletal muscle, (O	(D) EP skeletal
muscle, (t	s) P skeletal muscle, (A	p) C
skeletal muscle; (A---A) -A) E, EP, P, C liver;
(V--V) E, EP, P, C plasma.
DISCUSSION
The results described in this paper can be sum-
marized as follows: Repeated administration of
estrogen to the immature female chick results in
rapid cell proliferation, formation of tubular
gland cells, and appearance of specific egg white
proteins such as lysozyme and ovalbumin in the
oviduct. Concomitant administration of proges-
terone antagonizes the above characteristic effects
of estrogen. Such an antagonistic effect of pro-
gesterone can best be explained by the following
tentative hypothesis based on the data presented
herein : Under the influence of estrogen the pro-
liferation of various cell types in the magnum is
stimulated, among which are those cells destined
to become tubular gland cells and to synthesize
lysozyme and ovalbumin as shown by histological
and immunologic studies. Proliferation of such
potential tubular gland cells appears to com-
Total
lipid,
g/100
ml serum
Phospho-
lipid
phos-
phorus,
mg/100
ml plasma
Phosphoprotein
phosphorus,
mg/100 ml plasma
Control 0 .44 5.1 Undetectable
170-estradiol
benzoate*
1 .81 15.1 9.9
170-estradiol
benzoate* +
progesterone
1 .99 16 .1 9 .8
Progesterone* 0.64 4 .8 UndetectableE
F-
M:
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I-
w
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F-
0
0 10
01	
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18
	
24
TI ME(hr)
FIGURE 11 Effect of estrogen, progesterone, and
their combination on total wet and dry weight of chick
oviduct. Chicks were given a single injection of either
17/3-estradiol benzoate (E) 1 mg per chick, or proges-
terone (P) 1 mg per chick, or their combination (EP)
1 mg each per chick, or control sesame oil (C). At
indicated times after the hormone treatment, total
wet and dry weights were determined . The insert
shows the changes in dry weight . Each point represents
the means f sFM of four chicks.
mence before the appearance of lysozyme, which
is indicated by the difference in the time course of
the estrogen-induced increase in total DNA
content and of the appearance of lysozyme (Fig.
2 and Table I). The proliferation of these cells is
prevented by concomitant administration of pro-
gesterone as indicated by biochemical as well as
histological findings . Our data also suggest that
once such cell proliferation occurs, synthesis of
lysozyme and ovalbumin is not inhibited by
progesterone when administered with estrogen.
Thus, as shown in Table II and Figs. 3 d, 4 d,
5 c, and 8, when estrogen is administered before
initiation of progesterone treatment, tubular gland
cells and lysozyme are present after 5 days, with
the increase in quantity proportionate to the
length of the delay in the onset of progesterone
administration. Furthermore, progesterone appears
to prevent the estrogen-induced appearance of
lysozyme and ovalbumin by inhibiting the forma-
tion of potential tubular gland cells . On the basis
of the foregoing discussion, we propose that estro-
gen-induced proliferation of a specific cell type,
i.e. tubular gland cells, plays an important role
in the subsequent events of differentiation of
tubular gland cells characterized by the appear-
ance of both lysozyme and ovalbumin . A similar
proposal has been made by Stockdale and Topper
(45), who have shown that in mouse mammary
gland, DNA synthesis in the presence of insulin
and hydrocortisone is necessary for prolactin to
stimulate new casein synthesis. In addition, an-
drogens appear to inhibit new casein synthesis by
blocking the preceding insulin-mediated DNA
synthesis (46) . Thus, this effect of androgens
appears to be comparable to the effect of pro-
gesterone described above.
Attempts to localize the primary site of the
antagonistic effect of progesterone have been
made. An antiestrogenic compound such as
MER-21 has been shown to inhibit effects of estro-
gen in rat uterus by largely blocking the uptake
of estrogen into the tissue (47). However, in
chick oviduct, progesterone does not inhibit
either the absorption of estrogen from the injection
site or the uptake of estrogen into the oviduct .2
Early changes including the increased permeability
of the oviduct to a-aminoisobutyric acid and water
are not affected by progesterone as shown in Figs .
10 and 11 . This suggests that the antagonistic
effect of progesterone on specific cell proliferation
is probably not directly related to these early
estrogen effects .
The effect of estrogen to increase permeability
to amino acids (41-43) and water (44) has been
also demonstrated in the mammalian uterus .
However, many notable differences exist between
chick oviduct and mammalian uterus. For ex-
ample, rat uterus possesses a marked ability to
accumulate estrogen due to the presence of a
binding substance(s) as shown by Jensen and his
coworkers (48, 49), and by Gorski and his collab-
orators (50, 51), whereas chick oviduct does not
seem to possess such an apparent feature (52) .
This apparent lack of a binding substance might
be one of the reasons why the minimum threshold
dose of estrogen to cause a similar extent of increase
in wet weight in 3-5 days is much higher in chick
oviduct (1 .6 mg/kg body weight) (2) than in rat
uterus (1 µg/kg body weight) (53) . Testosterone,
which is synergistic to estrogen in chick oviduct,
is one of the potent antiestrogenic compounds in
rat uterus (54) . Progesterone is a potent antagonist
to estrogen at a dose of about 1 : 1 for the increase
in wet weight in chick oviduct. On the other hand,
in rat uterus, a ratio of 150-1500 of progesterone
to estrogen is necessary for progesterone to cause a
2 Unpublished observation : T. Oka and R, T. Schimke.
TAKAMI OKA AND ROBERT T . SCHIMKE Hormone Interaction in Oviduct Development 829small decrease in the estrogen-stimulated increase
in wet weight (55). The above characteristic dif-
ferences are of interest from the standpoint of
comparative endocrinology of the female genital
tract of mammals and birds.
An antagonistic as well as a synergistic effect of
combined treatment with progesterone and estro-
gen on the oviduct weight increase has been
described by several workers (13-18) . Dorfman
and Dorfman (16) have reported that these con-
flicting data result from the difference in the
intensity of estrogen stimulation used, in that at
the near maximal dose of estrogen administered,
the effect of estrogen is antagonized by proges-
terone, while at the minimal dose of estrogen,
progesterone is synergistic to estrogen . In this
paper, we have used the near maximal dose of
estrogen (1 mg/day per chick) and have presented
evidences of an antagonistic effect of progesterone
on estrogen. This evidence confirms partially the
report by Dorfman and Dorfman . However, we
have found that dual effects of progesterone, that
is, inhibitory and stimulative, can be seen even
at the near maximal dose of estrogen, depending
on the developmental stage of oviducts. Prelim-
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